Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture ...

Delhi HC reinstates injunction on Zydus, halting sale of breast cancer drug Sigrima: Shardul Nautiyal, Mumbai Friday, October 18, 2024, 18:15 Hrs [IST] In another significant setb ...

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate tablets USP, 0.1 mg.

Adani Enterprises, RIL, Zomato, and Mahanagar Gas are other stocks to watch before going into trade on Friday.

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

The fund house increased its holdings in 424 stocks which include Zydus Wellness, HDFC Bank, Punjab & Sind Bank, New India ...

ICMR partners with Zydus Lifesciences for Desidustat phase-2 trials in sickle cell disease patients, aiming for innovative ...

Indian stock market struggled to maintain momentum on Wednesday, October 16, with both the Sensex and Nifty closing in the ...

The Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations ...

The Indian Council of Medical Research (ICMR) has partnered with Zydus Lifesciences to begin Phase 2 clinical trials of Desidustat for treating sickle cell disease, a blood disorder. A pact was ...

Stocks including Reliance Industries, HCL Tech, Garuda Construction, JSW Infra, Angel One, IOB, Can Fin Homes, Zydus Life, ...